K060964

Substantially Equivalent

ARCHITECT BNP ASSAY, MODEL 8K28

Applicant: Fujirebio Diagnostics,Inc.
Product code: NBC
Advisory panel: Clinical Chemistry
Date received: 2006-04-07
Decision date: 2006-05-25
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Malvern, PA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.